AAAAAA
Results:
1-9
|
Results: 9
Authors:
Gross, NJ
Citation: Nj. Gross, The COLD standard for chronic obstructive pulmonary disease, AM J R CRIT, 163(5), 2001, pp. 1047-1048
Authors:
Gross, NJ
Kellam, M
Young, J
Krishnasamy, S
Dhand, R
Citation: Nj. Gross et al., Separation of alveolar surfactant into subtypes - A comparison of methods, AM J R CRIT, 162(2), 2000, pp. 617-622
Authors:
Dhand, R
Young, J
Teng, Y
Krishnasamy, S
Gross, NJ
Citation: R. Dhand et al., Is dipalmitoylphosphatidylcholine a substrate for convertase?, AM J P-LUNG, 278(1), 2000, pp. L19-L24
Authors:
Dolovich, MB
MacIntyre, NR
Anderson, PJ
Camargo, CA
Chew, N
Cole, CH
Dhand, R
Fink, JB
Gross, NJ
Hess, DR
Hickey, AJ
Kim, CS
Martonen, TB
Pierson, DJ
Rubin, BK
Smaldone, GC
Citation: Mb. Dolovich et al., Consensus statement: Aerosols and delivery devices, J AEROSOL M, 13(3), 2000, pp. 291-300
Authors:
Khoukaz, G
Gross, NJ
Citation: G. Khoukaz et Nj. Gross, Effects of salmeterol on arterial blood cases in patients with stable chronic obstructive pulmonary disease - Comparison with albuterol and ipratropium, AM J R CRIT, 160(3), 1999, pp. 1028-1030
Authors:
Dhand, R
Young, J
Krishnasamy, S
Possmayer, F
Gross, NJ
Citation: R. Dhand et al., Influence of phospholipid composition on the properties of reconstituted surfactants, LUNG, 177(3), 1999, pp. 127-138
Authors:
Niewoehner, DE
Erbland, ML
Deupree, RH
Collins, D
Gross, NJ
Light, RW
Anderson, P
Morgan, MA
Citation: De. Niewoehner et al., Effect of systemic glucocorticoids on exacerbations of chronic obstructivepulmonary disease, N ENG J MED, 340(25), 1999, pp. 1941-1947
Authors:
Mahler, DA
Donohue, JF
Barbee, RA
Goldman, MD
Gross, NJ
Wisniewski, ME
Yancey, SW
Zakes, BA
Rickard, KA
Anderson, WH
Citation: Da. Mahler et al., Efficacy of salmeterol xinafoate in the treatment of COPD, CHEST, 115(4), 1999, pp. 957-965
Authors:
Gross, NJ
Citation: Nj. Gross, Anticholinergic agents as bronchodilators, LUNG BIOL H, 134, 1999, pp. 59-72
Risultati:
1-9
|